Spoken Alpha
PetVivo Holdings, Inc.
PetVivo Holdings manufactures and commercializes veterinary medical devices made from protein-based biomaterials that mimic natural tissue. The company's lead product, Spryng®, is an intra-articular injection for treating osteoarthritis and joint lameness in dogs and horses.
PetVivo Holdings, Inc.
Behavioral analysis
Disclosures
Extracted from Unknown source, 2026-07-26.
Transcripts
We index calls for roughly 3,000 US-listed companies. If you'd like us to add PETVW, reply to your welcome email and we'll prioritize it.
History
Reported quarters with consensus, surprise, and 1-day reaction context.
Executives who appear on this company's earnings calls in our corpus, with role and tenure sourced from SEC filings. Click any name for the full role timeline and call appearance history. Per-executive behavioral deviation metrics are available to research subscribers.
API
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for PETVW.
$ curl https://api.spokenalpha.com/v1/companies/PETVWFAQ
Spoken Alpha indexes PETVW's earnings call transcripts at https://spokenalpha.com/companies/PETVW. Each call links to attributed speakers and parsed analyst Q&A. PetVivo Holdings, Inc.'s own investor relations page is at https://www.petvivo.com/investors.